Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company

Ray Moynihan

doi:10.1007/s11673-020-09965-y

Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company

Ray Moynihan^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Abstract

Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.

Original language	English
Journal	Journal of Bioethical Inquiry
Early online date	24 Mar 2020
DOIs	https://doi.org/10.1007/s11673-020-09965-y
Publication status	E-pub ahead of print - 24 Mar 2020

Fingerprint

Cite this

Moynihan, R. (2020). Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company. Journal of Bioethical Inquiry. https://doi.org/10.1007/s11673-020-09965-y

@article{7c328749863e49fa9ff085d2988688f9,

title = "Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company",

abstract = "Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.",

author = "Ray Moynihan",

year = "2020",

month = "3",

day = "24",

doi = "10.1007/s11673-020-09965-y",

language = "English",

journal = "New Zealand bioethics journal",

issn = "1176-7529",

publisher = "Springer",

}

TY - JOUR

T1 - Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company

AU - Moynihan, Ray

PY - 2020/3/24

Y1 - 2020/3/24

N2 - Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.

AB - Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.

UR - http://www.scopus.com/inward/record.url?scp=85083394515&partnerID=8YFLogxK

U2 - 10.1007/s11673-020-09965-y

DO - 10.1007/s11673-020-09965-y

M3 - Comment/debate

C2 - 32212056

JO - New Zealand bioethics journal

JF - New Zealand bioethics journal

SN - 1176-7529

ER -

Access to Document

10.1007/s11673-020-09965-y

Link to publication in Scopus